Trial Profile
Catheter-Directed Venous Thrombolysis in Acute Iliofemoral Vein Thrombosis, an Open Randomized, Controlled, Clinical Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 May 2021
Price :
$35
*
At a glance
- Drugs Alteplase (Primary) ; Heparin
- Indications Deep vein thrombosis; Postphlebitic syndrome
- Focus Therapeutic Use
- Acronyms CaVenT
- 29 Apr 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 14 Dec 2011 Results published in the Lancet.
- 13 Dec 2011 Primary endpoint 'Disease-occurrence-rate' has been met, according to results presented at the 53rd Annual Meeting and Exposition of the American Society of Hematology.